Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Interim report January – September 2017

CEO’s comments EQL Pharma continues to show weak numbers in parity with our previously announced financial outlook. The temporary withdrawal of Hydroxyzine EQL Pharma continues to effect sales and earnings. During the quarter, the drug Zonisamid EQL Pharma has been launched on the Danish market, while at the same time the drug Eletriptan EQL Pharma has been approved within the framework of a DCP. We continue to develop our portfolio and in total our pipeline has been expanded with three products, both in licensed products and developmental products are represented in the expansion.

Press invitation: Ericsson Capital Markets Day 2017

· Management presentations in New York on November 8, 2017, from 9am EST · Live webcast between 9am and 4pm ESTEricsson (NASDAQ: ERIC) will hold its Capital Markets Day on November 8, 2017 in New York, New York. You are welcome to join Ericsson's management team for the latest update on our strategy and business.   The presentations will start at 9 am EST on November 8, 2017 and the event will be webcast live on Ericsson’s website ERICSSON CAPITAL MARKETS DAY 2017 Venue: Convene, 117 W 46th Street, New York 10036

NRC Group has completed the acquisition of Fibertech AS

Reference is made to the announcement on 10 October 2017 by NRC Group ASA ("NRC Group" or the "Company") regarding the agreement for NRC Group's acquisition of Fibertech AS ("Fibertech"). NRC Norge AS, a wholly owned subsidiary of NRC Group, has today completed the acquisition of Fibertech. In connection with the acquisition, the board of directors of the Company has resolved to issue 512,895 new shares in the Company at a price per share of NOK 61.50. The new shares are issued as partial consideration to the sellers of Fibertech pursuant to an authorization granted by the Company's

Glas Trösch selects IFS Applications

ERP solution from IFS to be used across countries  IFS , the global enterprise applications company, announces that Glas Trösch , a Europe-wide operating Swiss manufacturer and processer of glass, has decided to implement IFS ApplicationsGlas Trösch will implement the IFS solution at several production locations. The software will map central business processes of Glas Trösch and enable a continuous flow of information, simplify processes, improve responsiveness, provide precise and up-to-date performance data, and

Pihlajalinna Plc publishes January–September 2017 Interim Report on Thursday, November 9, 2017

Pihlajalinna Plc    Media Release     24 October 2017 at 11.00 a.m. Pihlajalinna Plc publishes January–September 2017 Interim Report on Thursday, November 9, 2017 Interim Report Pihlajalinna Plc will publish the Interim Report for the period January 1–September 30, 2017 on Thursday, November 9, 2017 at 08:00 a.m. The report will be available on the company website investors.pihlajalinna.fi. Press and analyst meeting A meeting for analysts and the press, conducted in Finnish, will be held on Thursday, November 9, 2017 at 10:00 a.m. Meeting will take place in the Hotel Kämp

Diamyd Medical strengthens GABA portfolio with new license

Diamyd Medical has concluded a new exclusive licensing agreement with University of California, Los Angeles (UCLA) Technology Development Group on behalf of UC Regents. The license relates to new patent applications for the therapeutic use of GABA (gamma-aminobutyric acid) with positive allosteric modulators of the GABAA receptor to enhance beta cell regeneration, survival and immunomodulation.“This new GABA license together with our existing license, patent applications, and our proprietary GABA study drug Remygen®, provide a strong development platform to fully realize the therapeutic and

Interim Report January – September 2017

· Order intake was MSEK 3,939.3 (3,438.2), which is an overall growth of 14.6% adjusted to 1.4% for acquisitions (MSEK 448.0) and currency effects (MSEK 5.0) · Net sales were MSEK 3,850.4 (3,317.0), which is an overall growth of 16.1% adjusted to 3.0% for acquisitions (MSEK 430.6) and currency effects (MSEK 4.9) · Operating profit was MSEK 505.5 (404.3), representing a 25.0% increase with an operating margin of 13.1 (12.2)% · Earnings after tax were MSEK 352.8 (298.3), an increase of 18.3% · Earnings per share were SEK 3.09 (2.62), an increase of 17.9% · Cash flow from

Sobi™ establishes new leadership structure and appoints Torbjörn Hallberg as General Counsel

Swedish Orphan Biovitrum AB (publ)  (Sobi™) today announces the establishment of a new leadership structure; Executive Committee, to replace the Executive Leadership Team in its current form. Sobi also announces the appointment of Torbjörn Hallberg as new General Counsel, Head of Legal Affairs. The Executive Committee is Sobi’s decision-making body. Regularly, the Executive Committee will be expanded with key functions, to an Extended Leadership Team. Sobi’s Executive Committee consists of: Chief Executive Officer – Guido OelkersChief Financial Officer –

Talkpool wins global frame agreement with Digicel Group

After more than 11 years of close collaboration between Digicel Haiti and Talkpool, Digicel is now expanding its relationship with Talkpool by signing a 10-year global framework agreement between Digicel Group and Talkpool AG for the delivery of telecom network operation and maintenance services to all of Digicel's 33 markets throughout world.Digicel has until now had a decentralized structure with multiple suppliers providing operation and maintenance services in various markets but wishes to centralize and consolidate its supplier base to drive efficiencies and benefit from economies of

Peab rebuilds and extends the Södra Älvsborg Hospital in Borås

Peab has been commissioned by developer Västfastigheter to rebuild and extend sections of Södra Älvsborg Hospital. In total the contract is worth SEK 1,025 million and the entire project is expected to be completed in 2021.In order to meet current and future needs in healthcare the infection unit, psychiatrics and medicine laboratory at Södra Älvsborg Hospital will go through a thorough renewal and refitment. In 2016 the Västra Götalandsregionen regional board adopted a plan for three major investments in healthcare at Södra Älvsborg Hospital in Borås. Peab is now starting up

HiQ behind Wärtsilä’s global intranet

In close collaboration with Wärtsilä, HiQ has developed the concept for their new global intranet.18,000 employees in 70 countries benefit from the improvements.“I’m happy that we have delivered yet another solution that simplifies people’s everyday lives,” says Jukka Rautio, Managing Director at HiQ FinlandWärtsilä is a global leader in advanced technologies and complete lifecycle solutions for the marine and energy markets. The new social, mobile intranet is providing targeted information for users based on individual needs and intuitive search experience with well-planned and

Camanio Care carries out rights issue through settlement in order to finance international sales

In connection with the Rights Issue announced by Camanio Care May 12th 2017, the company also took a loan of 2,1 MSEK from Recall Capital AB. The capital is mainly being used to develop Camanio Care’s international sales channels and reference clients. Now, the entire amount is fully repaid through a directed issue through settlement.   -          We work continuously with the capital structure of the company and with long term funding to optimise our operations. Therefore, we have established a good relationship with Recall Capital as a long-term partner. Recall also helps Camanio Care

Ahlstrom-Munksjö PureArmor™ breathable impervious nonwoven fabric combines superior protection with great comfort

AHLSTROM-MUNKSJÖ OYJ PRESS RELEASE, OCTOBER 24, 2017 at 9:00 CEST Ahlstrom-Munksjö, a global leader in fiber-based materials, announces the launch of Ahlstrom-Munksjö PureArmor™, a breathable impervious fabric for blood borne pathogen and cleanroom apparel protection. “PureArmor™ eliminates the need to choose between comfort and protection. It offers the highest possible level of protection for sensitive environments without sacrificing the wearer's comfort, which is unique when compared to fabrics frequently used in cleanroom apparel,” said Lionel Bonte, Vice President, Medical,

Tilgin takes the next step towards Smart Home and IoT with HKBN

Stockholm, Sweden, October 24, 2017: Tilgin, a leading provider of gateway software and device management software for broadband access & Smart Home Solutions is proud to announce its next step towards Smart Home and IoT.HKBN Group (“HKBN”) is Hong Kong’s largest provider of residential high-speed fiber broadband services and a fast-growing enterprise solutions provider. The Group already offers a full range of telecommunications solutions for both the residential and enterprise markets and is now launching a complete smart home solution that includes smart home devices, a subscriber app

Coor extends agreement with Borealis

Borealis extends its collaboration with Coor regarding delivery of IFM (integrated facility management) services. The agreement is worth some SEK 100 m annually and runs from 1 April 2018.The agreement implies that Coor will continue to develop and deliver integrated workplace and property services to Borealis’ some 1,000 staff in 140 buildings at the company’s Stenungsund plant. Borealis produces products including plastic compounds for pipe systems, power and communications cables and advanced packaging solutions. “Borealis’ operations are carried out in a complex production

Seamless announces shareholders’ support for share issue

The Board of Seamless Distribution wishes to express its gratitude to the Company’s four largest shareholders, including the Chairman John Longhurst (together representing over 30 % of the Company’s share capital), who confirm their support (and intention to provide written undertakings) for the proposed rights issue, and their support for the strategic initiatives announced by the Board of Seamless, in our press release last week, and in the coming days in a call for an EGM.    I wish to take this opportunity to apologise to our shareholders. An investment in Seamless Distribution over

Excellent quarter, further steps in transformation

UPM-Kymmene Corporation      Interim Report          24 October 2017 at 09:35 EET Excellent quarter, further steps in transformation Q3 2017 highlights · Comparable EBIT increased by 12% to EUR 351 million (314 million in Q3 2016). · Good growth in deliveries and strong operational efficiency with no significant maintenance activity. · Strong operating cash flow at EUR 486 million (506 million). · Net debt decreased to EUR 623 million (1,479 million). · UPM announced a new focused growth project at the UPM Chudovo plywood mill in Russia. · UPM announced

Combitech’s interim report for January-September 2017

Combitech, the Nordic technology consultancy company within the defence and security group, Saab AB, continues to report excellent results. For the first three quarters of the year, the company has increased both sales and profit.Events during the third quarter: · Atlas Copco has entered into a collaboration with Combitech concerning mining digitalisation. Combitech’s expertise from the digitalisation of aviation, defence and telecommunications was decisive when Atlas Copco choose the company as its partner.  The collaboration will among other things build upon Saab’s technical

Cereno Scientific announces first subjects dosed in clinical study with drug candidate CS1

Cereno Scientific (Aktietorget: “CRNO B”), a pharmaceutical company developing a new preventive medicine to treat thrombosis-related disease, today announced dose administration for the first subjects in its recently approved clinical study with drug candidate, CS1.The study, which is being conducted together with Cereno Scientific’s clinical research partner, CTC, is assessing the safety and tolerability, as well as the pharmacokinetics, of CS1 in adults with borderline hypertension and obesity. It is also investigating the efficacy of CS1 on biomarkers related to risk for thrombosis-

Financial reporting dates for Atlas Copco

Stockholm, Sweden, October 24, 2017: Atlas Copco, a leading provider of sustainable productivity solutions, will issue financial information on the following dates.2018              January 26                          Preliminary 2017 report                                                                  Q4 2017 result                                                                   Silent period starts December 28, 2017                       April 24                                Annual General Meeting                         April 25                                Q1 2018

CTT Systems releases two Zonal Drying™ orders of total eight Boeing Next-Generation 737-800s

CTT Systems AB (“CTT”), the market leader in aircraft humidity control systems, announces two Zonal Drying™ Buyer Furnished Equipment orders for a total of eight Boeing Next-Generation 737-800 aircraft. The eight Zonal Drying™ systems will be line fitted by Boeing from December 2017 to December 2018.Peter Landquist, VP Sales & Marketing, CTT Systems AB, comments: “We see an uptick in airline demand for our Zonal Drying™ system, mainly driven by higher passenger load-factors and from high-density seat layouts. Several airlines that increased seat capacity by adding more seats now experience

Smart Eye Interim Report 1 January–30 September 2017

Summary Q3 2017 · Net revenue amounted to TSEK 12,945 (10,092), equivalent to an increase of 28%. · The operating result was TSEK –8,180 (–4,634), which is in line with the adopted expansion, with investments in primarily personnel and geographical expansion. · The result after financial items was TSEK –8,285 (–4,876). · The result after tax per share was negative. · Cash and cash equivalents amounted to TSEK 27,468 as at the end of September. · The revenue of the Applied Solutions business area increased by 96%. · Smart Eye was awarded a third design win from a

Reminder: Invitation to presentation of Orkla's third quarter 2017 results, Wednesday 25 October

Orkla will report its third quarter 2017 results on Wednesday, 25 October 2017 at 7.00 a.m. CET. The quarterly report and the presentation material will be available at this time at www.orkla.com.The quarterly results will be presented at 8.00 a.m. in Oslo Concert Hall, Munkedamsveien 14, Oslo. The presentation and subsequent Q&A session will be held in English and may be viewed in a live webcast at www.orkla.com or followed by telephone. Dial-in details: +47 21 03 33 94. Pincode: 6491460.Orkla ASAOslo, 24 October 2017Ref.:IR & Communications ManagerElise HeidenreichTel.: +47

There are no items matching the current filter
There are no more items matching the current filter
Back to top